Cancer Immunology Research
Scope & Guideline
Exploring the Synergy of Immunology and Oncology
Introduction
Aims and Scopes
- Cancer Immunotherapy Mechanisms:
The journal extensively covers the mechanisms of various cancer immunotherapies, including checkpoint inhibitors, CAR T-cell therapies, and immune-modulating agents, highlighting their biological underpinnings and clinical implications. - Tumor Microenvironment Dynamics:
Research frequently addresses the role of the tumor microenvironment in modulating immune responses, including studies on immune cell infiltration, metabolic reprogramming, and interactions between tumor and immune cells. - Translational Research and Clinical Applications:
Cancer Immunology Research bridges basic research and clinical applications, providing insights into how laboratory findings can be translated into effective treatments, including novel vaccine strategies and combination therapies. - Genomic and Proteomic Insights:
The journal publishes studies that leverage genomic and proteomic technologies to identify biomarkers and therapeutic targets, enhancing personalized medicine approaches in cancer treatment. - Emerging Technologies in Immunotherapy:
There is a strong emphasis on innovative technologies, such as CRISPR gene editing, single-cell sequencing, and machine learning applications, aimed at improving the efficacy and safety of cancer immunotherapies.
Trending and Emerging
- Combination Immunotherapy Approaches:
There is an increasing focus on combination therapies that integrate various immunotherapeutic strategies, such as combining checkpoint inhibitors with CAR T-cell therapy or other immune modulators, to enhance overall treatment efficacy. - Microbiome and Immunotherapy Interactions:
Recent studies are exploring the role of the gut microbiome in modulating immune responses to cancer therapy, revealing how microbial communities can influence treatment outcomes and immune system dynamics. - Personalized Cancer Vaccines:
The development of personalized cancer vaccines based on individual tumor neoantigens is gaining prominence, emphasizing tailored approaches to immunotherapy that leverage specific patient tumor profiles. - Role of Metabolism in Immune Function:
Research increasingly focuses on the metabolic pathways of immune cells in the tumor microenvironment, exploring how metabolic reprogramming can enhance or inhibit anti-tumor immunity. - Single-Cell and Spatial Transcriptomics:
The application of single-cell RNA sequencing and spatial transcriptomics is becoming more prevalent, providing deeper insights into the cellular composition and functional states of immune cells in tumors, which is crucial for understanding resistance mechanisms.
Declining or Waning
- Traditional Chemotherapy Studies:
Research focusing on traditional chemotherapy alone, without immunological context, appears to be decreasing, as the field shifts towards understanding how to synergize chemotherapy with immunotherapy. - Basic Descriptive Studies on Tumor Cells:
There has been a noticeable reduction in purely descriptive studies regarding tumor cell biology, with a greater emphasis now placed on functional studies that explore the tumor-immune interaction. - Standalone Immunomodulatory Agents:
The focus on isolated immunomodulatory agents, without combination strategies or contextual understanding of their mechanisms, is less prevalent, indicating a trend towards integrated approaches in immunotherapy. - General Immune Response Studies:
Research that broadly addresses immune responses without specific relevance to cancer immunology or therapy is becoming less common, as the journal favors studies with direct implications for cancer treatment.
Similar Journals
Trends in Cancer
Transforming Cancer Research Through Scholarly ExcellenceTrends in Cancer is a leading journal published by CELL PRESS, dedicated to advancing the field of cancer research and oncology. Since its inception in 2015, the journal has rapidly gained a reputation for excellence, securing both Q1 rankings in Cancer Research and Oncology categories for 2023 and boasting impressive Scopus ranks—#13 out of 404 in Medicine Oncology and #9 out of 230 in Biochemistry, Genetics and Molecular Biology, thus placing it in the top 4% of its field. The journal aims to publish high-quality, innovative research that offers new insights into cancer biology and treatment strategies. With a commitment to scholarly rigor and a broad scope that encompasses molecular mechanisms to therapeutic approaches, Trends in Cancer serves as an essential resource for researchers, professionals, and students eager to stay informed about the latest developments in cancer science. Although it is not an open-access journal, its contributions are pivotal in shaping the future of cancer research.
Cellular & Molecular Immunology
Elevating Research in Cellular and Molecular ImmunologyCellular & Molecular Immunology is a prestigious peer-reviewed journal published by the CHIN SOCIETY IMMUNOLOGY. As a leading journal in the fields of immunology and infectious diseases, it proudly holds a Q1 designation across multiple categories, including Immunology, Allergy, and Medicine (Miscellaneous), reflecting its commitment to excellence and impactful research. With an ISSN of 1672-7681 and an E-ISSN of 2042-0226, the journal has been essential reading since its inception in 2004, continuously gathering insights from cutting-edge studies. It ranks impressively within Scopus, with positions in the 7th, 8th, and 9th percentile in relevant categories, establishing it as a cornerstone for researchers, clinicians, and students alike. The journal offers an extensive range of original research articles, reviews, and clinical studies, ensuring that readers stay at the forefront of immunological discovery. Whether you are interested in basic immunology, infectious diseases, or evolving therapies, Cellular & Molecular Immunology serves as an invaluable resource for advancing your knowledge and engagement in this dynamic field.
HEMATOLOGICAL ONCOLOGY
Advancing the Frontiers of Hematological ResearchHEMATOLOGICAL ONCOLOGY, published by Wiley, is a premier journal in the fields of cancer research, hematology, and oncology, with a rich history of publication dating back to 1983. With an impact factor indicative of its influential standing—ranking in the second quartile in multiple categories including Cancer Research, Hematology, and Oncology—this journal serves as a vital resource for researchers, clinicians, and students alike. HEMATOLOGICAL ONCOLOGY is based in the United Kingdom and focuses on the advancements and challenges in the understanding and treatment of hematological malignancies. While it does not offer open access options, its rigorous peer-review process ensures that all published articles are of the highest quality, contributing to the ongoing dialogue and research in this critical area of medicine. With its commitment to disseminating impactful research, HEMATOLOGICAL ONCOLOGY remains an essential platform for driving innovation and collaboration within the global scientific community.
EXPERT REVIEWS IN MOLECULAR MEDICINE
Elevating Understanding of Health and DiseaseEXPERT REVIEWS IN MOLECULAR MEDICINE, published by Cambridge University Press, stands at the forefront of research in the fields of Molecular Biology and Molecular Medicine. With an impressive impact factor reflecting its Q1 status in both relevant categories, this journal serves as an essential platform for disseminating cutting-edge reviews and critical assessments that are vital for advancing our understanding of molecular mechanisms in health and disease. Established in 1997 and continuously evolving until 2024, it features contributions from leading experts that highlight emerging trends and innovative methodologies. Researchers, professionals, and students are encouraged to engage with the content, benefiting from the journal’s rigorous peer-review process and its commitment to academic excellence, making it a valuable resource within the scientific community.
GENES AND IMMUNITY
Pioneering Insights into Genetic Influences on ImmunityGENES AND IMMUNITY, published by SpringerNature, is a leading scholarly journal dedicated to advancing the field of genetics and immunology. With an impressive impact factor and a distinguished ranking in the Q1 quartile of both Genetics and Immunology disciplines for 2023, this journal serves as a pivotal platform for researchers and professionals looking to explore the intricate relationships between genetic factors and immune responses. Established in 1999 and continuously published until 2024, it features high-quality peer-reviewed research articles, reviews, and commentary that address critical issues and recent advancements in the field. The journal adheres to rigorous academic standards, evidenced by its strong Scopus rankings, making it a valuable resource for students, researchers, and practitioners alike who are seeking to deepen their understanding of genetics' role in immunity. For those looking to keep abreast of cutting-edge insights, GENES AND IMMUNITY is an essential read.
HUMAN IMMUNOLOGY
Illuminating the Pathways of Human ImmunologyHUMAN IMMUNOLOGY, published by Elsevier Science Inc, serves as a critical platform for disseminating research in the fields of immunology and allergy, as well as various aspects of miscellaneous medicine since its inception in 1980. With an ISSN of 0198-8859 and E-ISSN 1879-1166, this journal is pivotal for researchers and practitioners looking to advance their understanding of human immune responses and related conditions. The journal currently holds a respectable position within its field, as highlighted by its 2023 Scopus ranks—#114/233 in Immunology and Allergy and #132/236 in Immunology and Microbiology. Moreover, it maintains a Q2 quartile ranking in both Immunology and Allergy and miscellaneous Medicine, underscoring its influence and reach within the scientific community. Although it does not currently offer Open Access options, HUMAN IMMUNOLOGY remains dedicated to providing valuable insights and fostering academic discourse within its discipline, characterized by a rigorous peer-review process and a focus on innovative research trajectories.
Science Immunology
Unraveling Complexities, Empowering DiscoveriesScience Immunology, published by the American Association for the Advancement of Science, is a leading journal in the field of immunology, recognized for its significant impact and rigor in advancing our understanding of immune responses and complex diseases. With an impressive impact factor that places it in the Q1 category of both immunology and allergy, as well as miscellaneous medicine, this journal is ranked #7 and #8 in their respective Scopus categories, reflecting its high-quality research output. Since its inception in 2016, Science Immunology has been at the forefront of interdisciplinary immunological research, fostering crucial insights that link immunology with pressing health challenges. The journal is committed to providing open access to its content, ensuring that groundbreaking findings are accessible to a global audience of researchers, professionals, and students. Its anthology not only addresses fundamental immunological mechanisms but also enhances the dialogue on translational applications and therapeutic interventions, solidifying its position as an essential resource within the scientific community.
CANCER CELL
Advancing the Frontiers of Cancer ResearchCancer Cell, published by Cell Press, represents a pinnacle of research in the fields of cancer research, cell biology, and oncology. With an impressive Impact Factor and ranking as Q1 in prestigious categories for both 2023 and previous years, this journal stands out as a vital resource for professionals and scholars dedicated to understanding the molecular underpinnings of cancer. Operating from Cambridge, MA, Cancer Cell has been an essential platform for innovative studies since its inception in 2002. Although it is not an Open Access journal, its rigorous peer-review process ensures that only the highest quality research is disseminated to the scientific community. Readers can expect to find a wealth of knowledge ranging from cutting-edge therapies to insights into tumor biology, thereby contributing significantly to the advancement of oncology. With rankings placing it among the top echelons of related fields—#2 in Cancer Research and #6 in Oncology—Cancer Cell is an indispensable reference for anyone committed to the fight against cancer.
INTERNATIONAL JOURNAL OF ONCOLOGY
Exploring the frontiers of oncology research.INTERNATIONAL JOURNAL OF ONCOLOGY is a leading academic publication dedicated to advancing the field of cancer research and treatment. Published by SPANDIDOS PUBL LTD in Greece, this journal, with ISSN 1019-6439 and E-ISSN 1791-2423, has established itself as a reputable source of peer-reviewed articles since its inception in 1993. With an impressive Q2 ranking in both Cancer Research and Oncology categories, as well as high Scopus ranks reflecting its significant contribution to the fields of Medicine and Biochemistry, the journal offers a platform for researchers, clinicians, and students alike to disseminate their findings and engage in dialogue surrounding innovative practices and breakthroughs. Although the journal follows a traditional subscription model, it continues to attract a diverse readership interested in the latest developments in oncological research, providing essential insights into cancer biology, therapeutics, and patient care. With a commitment to excellence, the INTERNATIONAL JOURNAL OF ONCOLOGY plays a vital role in shaping the future of oncology research and is a must-read for anyone passionate about advancing cancer treatment and prevention.
BMC IMMUNOLOGY
Advancing Knowledge in Immunological ResearchBMC Immunology is a prominent open-access journal published by BMC that has been at the forefront of immunological research since its inception in 2000. Based in the United Kingdom, this journal aims to advance the understanding of immune system functions and disorders through high-quality, peer-reviewed articles. With an impressive scope encompassing various facets of immunology, BMC Immunology has earned a Q3 ranking in the Immunology category according to the 2023 category quartiles, demonstrating its growing impact and relevance in the scientific community. Researchers and professionals will find valuable insights in its array of published works, spanning both foundational studies and innovative applications. The journal's commitment to open access ensures that cutting-edge research is freely available, fostering collaboration and advancement in the field. For those looking to stay updated on the latest developments in immunology, BMC Immunology stands as an essential resource for researchers, professionals, and students alike.